Subcapsular liver hematoma after fibrinolytic therapy for acute myocardial infarction: a rare case report

Subcapsular liver hematoma after fibrinolytic therapy for acute myocardial infarction: a rare case report

Authors

  • Morteza Safi Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Isa Khaheshi Cardiovascular Research Center, Modarres hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Mehdi Memaryan Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Mohammadreza Naderian Students’ Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran.

Keywords:

Thrombolytic Therapy, Hematoma, Liver, Myocardial Infarction

Abstract

Hemorrhagic complications of thrombolytic therapy are rare but also serious and sometimes life-threatening. Liver hematoma is a very uncommon complication following thrombolytic therapy. We present a rare case of sub-capsular liver hematoma following streptokinase therapy of acute myocardial infarction as a challenging condition. This case report highlights that emergency physicians and cardiologists should be familiar with the significant and uncommon complications of thrombolytic agents, particularly streptokinase which is used generally in under- developed countries.

Downloads

Published

16-01-2017

How to Cite

1.
Subcapsular liver hematoma after fibrinolytic therapy for acute myocardial infarction: a rare case report. Acta Biomed [Internet]. 2017 Jan. 16 [cited 2024 Mar. 29];87(3):318-20. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/5373